The DOI matches its Crossref record; 278 of the 278 references it cites were found in a registry or an index.
Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities
Abstract
Nitric oxide (NO) is a pleiotropic molecule critical to a number of physiological and pathological processes. The last decade has witnessed major advances in dissecting NO biology and its role in cancer pathogenesis. However, the complexity of the interactions between different levels of NO and several aspects of tumor development/progression has led to apparently conflicting findings. Furthermore, both anti‐NO and NO‐based anticancer strategies appear effective in several preclinical models. This paradoxical dichotomy is leaving investigators with a double challenge: to determine the net impact of NO on cancer behavior and to define the therapeutic role of NO‐centered anticancer strategies. Only a comprehensive and dynamic view of the cascade of molecular and cellular events underlying tumor biology and affected by NO will allow investigators to exploit the potential antitumor properties of drugs interfering with NO metabolism. Available data suggest that NO should be considered neither a universal target nor a magic bullet, but rather a signal transducer to be modulated according to the molecular makeup of each individual cancer and the interplay with conventional antineoplastic agents. © 2006 Wiley Periodicals, Inc. Med Res Rev, 27, No. 3, 317–352, 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Kasuno, K., Takabuchi, S., Fukuda, K., Kizaka-Kondoh, S., Yodoi, J., Adachi, T., Semenza, G. L., & Hirota, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308197200 · Cited by 226
RetractedHattori, Y., KASAI, K., & GROSS, S. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.014 · Cited by 80
RetractedChawla‐Sarkar, M., Bauer, J. A., Lupica, J. A., Morrison, B., Tang, Z., Oates, R. K., Almasan, A., DiDonato, J. A., Borden, E. C., & Lindner, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306111200 · Cited by 77
RetractedCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
Nitric oxide and the immune response
Bogdan, C. (2001) · Nature Immunology · doi:10.1038/ni1001-907 · Cited by 3,447
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal, B. B., Kumar, A. J., & Bharti, A. C. (2003) · PubMed · Cited by 2,550
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Progress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690 · cited 3×
“Overall, this p53mediated growth inhibition may be expected to provide a strong selection pressure for mutant p53 expression in malignant cells.(108) The p53 gene shows GC ! AT transitions in many human cancers—particularly at its CpG islands.”
BackgroundSurh, Y.-J., Chun, K.-S., Cha, H.-H., Han, S. S., Keum, Y.-S., Park, K.-K., & Lee, S. S. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00183-x · Cited by 1,620
Nathan, C., & Shiloh, M. U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.8841 · Cited by 1,469
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
Nitric oxide : biology and pathobiology
Ignarro, L. J. (2000) · Cited by 1,306
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
Phase I Clinical Trial of Oral Curcumin
Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0744 · Cited by 1,257
Sandler, R. S., Halabi, S., Baron, J. A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J. M., Karp, D. D., Loprinzi, C. L., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021633 · Cited by 1,136
Nitric oxide and superoxide in inflammation and immune regulation.
Guzik, T. J., Korbut, R., & Adamek-Guzik, T. (2003) · PubMed · Cited by 1,096
Nitric oxide synthases: which, where, how, and why?
Michel, T., & Feron, O. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119750 · Cited by 1,011
Nitric oxide in immunity and inflammation
Coleman, J. W. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00086-8 · Cited by 945
Ziche, M., Morbidelli, L., Choudhuri, R., Zhang, H. T., Donnini, S., Granger, H. J., & Bicknell, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119451 · Cited by 915
Nitric oxide in health and disease of the respiratory system
Ricciardolo, F. L. M., Sterk, P. J., Gaston, B., & Folkerts, G. (2004) · Physiological Reviews · doi:10.1152/physrev.00034.2003 · Cited by 903
Kim, Y.-M., Talanian, R. V., & Billiar, T. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.31138 · Cited by 887
Chemopreventive and therapeutic effects of curcumin
Duvoix, A., Blasius, R., Delhalle, S., Schnekenburger, M., Morceau, F., Henry, E., Dicato, M., & Diederich, M. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.09.041 · Cited by 866
The role of nitric oxide in cancer
XU, W., LIU, L. Z., LOIZIDOU, M., AHMED, M., & CHARLES, I. G. (2002) · Cell Research · doi:10.1038/sj.cr.7290133 · Cited by 826
Dimmeler, S., Haendeler, J., Nehls, M., & Zeiher, A. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.601 · Cited by 806
Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?
Ischiropoulos, H., & Beckman, J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17638 · Cited by 747
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Norbury, C. J., & Zhivotovsky, B. (2004) · Oncogene · doi:10.1038/sj.onc.1207532 · Cited by 701
The multifaceted roles of nitric oxide in cancer
Wink, D. (1998) · Carcinogenesis · doi:10.1093/carcin/19.5.711 · Cited by 682
Jaiswal, M., LaRusso, N. F., Burgart, L. J., & Gores, G. J. (2000) · PubMed · Cited by 653
Expressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III)
Förstermann, U., Boissel, J., & Kleinert, H. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.773 · Cited by 647
Nitric oxide synthase activity in human breast cancer
Thomsen, L., Miles, D., Happerfield, L., Bobrow, L., Knowles, R., & Moncada, S. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.274 · Cited by 626
Chemical basis of inflammation-induced carcinogenesis
Ohshima, H., Tatemichi, M., & Sawa, T. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00283-2 · Cited by 620
INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGET
Hobbs, A. J., Higgs, A., & Moncada, S. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.191 · Cited by 596
Mikkelsen, R. B., & Wardman, P. (2003) · Oncogene · doi:10.1038/sj.onc.1206663 · Cited by 592
L-arginine metabolism in myeloid cells controls T-lymphocyte functions
Bronte, V., Serafini, P., Mazzoni, A., Segal, D. M., & Zanovello, P. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00132-7 · Cited by 592
Self-citationWilson, K. T., Fu, S., Ramanujam, K. S., & Meltzer, S. J. (1998) · PubMed · Cited by 591
Kawamori, T., Lubet, R., Steele, V. E., Kelloff, G. J., Kaskey, R. B., Rao, C. V., & Reddy, B. S. (1999) · PubMed · Cited by 589
Davis, K. L., Martin, E., Turko, I. V., & Murad, F. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.203 · Cited by 584
Role of nitric oxide in carcinogenesis and tumour progression
Lala, P. K., & Chakraborty, C. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00256-4 · Cited by 570
Rescuing the function of mutant p53
Bullock, A. N., & Fersht, A. R. (2001) · Nature Reviews Cancer · doi:10.1038/35094077 · Cited by 568
S-nitrosylation in health and disease
Foster, M. W., McMahon, T. J., & Stamler, J. S. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(03)00028-5 · Cited by 558
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy
Almasan, A., & Ashkenazi, A. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00029-7 · Cited by 553
Essential Roles of S-Nitrosothiols in Vascular Homeostasis and Endotoxic Shock
Liu, L., Yan, Y., Zeng, M., Zhang, J., Hanes, M. A., Ahearn, G., McMahon, T. J., Dickfeld, T., Marshall, H. E., Que, L. G., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00131-x · Cited by 547
Bernstein, C. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00009-1 · Cited by 527
Serafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., & Borrello, I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0757 · Cited by 523
Self-citationPoly (ADP-ribose) polymerase, nitric oxide and cell death
Pieper, A. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01292-4 · Cited by 517
Multiple pathways of peroxynitrite cytotoxicity
Szabó, C. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(02)00507-6 · Cited by 506
At the Crossroads of Inflammation and Cancer
Clevers, H. (2004) · Cell · doi:10.1016/j.cell.2004.09.005 · Cited by 493
Hussain, S. P., Amstad, P., Raja, K., Ambs, S., Nagashima, M., Bennett, W. P., Shields, P. G., Ham, A. L., Swenberg, J. A., Marrogi, A. J., et al. (2000) · PubMed · Cited by 482
YC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1
Yeo, E.-J., Chun, Y.-S., Cho, Y.-S., Kim, J., Lee, J.-C., Kim, M.-S., & Park, J.-W. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.7.516 · Cited by 476
Marnett, L. J., Riggins, J. N., & West, J. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18022 · Cited by 476
Ambs, S., Merriam, W. G., Bennett, W. P., Felley‐Bosco, E., Ogunfusika, M. O., Oser, S. M., Klein, S., Shields, P. G., Billiar, T., & Harris, C. C. (1998) · PubMed · Cited by 472
Okamoto, T., Akaike, T., Sawa, T., Miyamoto, Y., van der Vliet, A., & Maeda, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102417200 · Cited by 468
Kimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T., D'Acquisto, F., Addeo, R., Makuuchi, M., & Esumi, H. (2000) · Blood · doi:10.1182/blood.v95.1.189 · Cited by 439
Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro
Wang, Y., Fei, D., Vanderlaan, M., & Song, A. (2004) · Angiogenesis · doi:10.1007/s10456-004-8272-2 · Cited by 430
Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer
Gallo, O., Fini-Storchi, I., Vergari, W. A., Masini, E., Morbidelli, L., Ziche, M., & Franchi, A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.587 · Cited by 427
Regulation of the Expression of Inducible Nitric Oxide Synthase
Kleinert, H., Schwarz, P. M., & Förstermann, U. (2003) · Biological Chemistry · doi:10.1515/bc.2003.152 · Cited by 423
Nitric oxide synthase activity in human gynecological cancer.
Thomsen, L., Lawton, F., Knowles, R. G., Beesley, J. E., Riveros‐Moreno, V., & Moncada, S. (1994) · PubMed · Cited by 417
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
Bronte, V., Kasic, T., Gri, G., Gallana, K., Borsellino, G., Marigo, I., Battistini, L., Iafrate, M., Prayer-Galetti, T., Pagano, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042028 · Cited by 396
Self-citationNitric oxide represses inhibitory κB kinase through S-nitrosylation
Reynaert, N. L., Ckless, K., Korn, S. H., Vos, N., Guala, A. S., Wouters, E. F. M., van der Vliet, A., & Janssen-Heininger, Y. M. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400588101 · Cited by 388
Biological significance of nitric oxide-mediated protein modifications
Gow, A. J., Farkouh, C. R., Munson, D. A., Posencheg, M. A., & Ischiropoulos, H. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00295.2003 · Cited by 385
Inhibition of NF-κB by S-Nitrosylation
Marshall, H. E., & Stamler, J. S. (2001) · Biochemistry · doi:10.1021/bi002239y · Cited by 379
Expression of nitric oxide synthase in human central nervous system tumors.
Cobbs, C., Brenman, J. E., Aldape, K., Bredt, D. S., & Israel, M. A. (1995) · PubMed · Cited by 367
S-Nitrosylation of mitochondrial caspases
Mannick, J. B., Schonhoff, C., Papeta, N., Ghafourifar, P., Szibor, M., Fang, K., & Gaston, B. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104008 · Cited by 363
Nitric oxide: NO apoptosis or turning it ON?
Brüne, B. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401261 · Cited by 361
A potential role of macrophage activation in the treatment of cancer
Klimp, A. H., de Vries, E. G. E., Scherphof, G. L., & Daemen, T. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00203-7 · Cited by 360
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Mollace, V., Muscoli, C., Masini, E., Cuzzocrea, S., & Salvemini, D. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.1 · Cited by 357
Kusmartsev, S. A., Li, Y., & Chen, S.-H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.779 · Cited by 355
Macarthur, M., Hold, G. L., & El-Omar, E. M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00475.2003 · Cited by 348
Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-κB
Ganster, R. W., Taylor, B. S., Shao, L., & Geller, D. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151239498 · Cited by 321
Xie, K., Huang, S., Dong, Z., Juang, S. H., Gutman, M., Xie, Q. W., Nathan, C., & Fidler, I. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1333 · Cited by 320
Cholangiocarcinoma: Molecular targeting strategies for chemoprevention and therapy
Sirica, A. E. (2005) · Hepatology · doi:10.1002/hep.20537 · Cited by 315
Tumor necrosis factor, cancer and anticancer therapy
MOCELLIN, S., ROSSI, C., PILATI, P., & NITTI, D. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.11.001 · Cited by 311
Self-citationLocal endostatin treatment of gliomas administered by microencapsulated producer cells
Read, T.-A., Sorensen, D. R., Mahesparan, R., Enger, P. Ø., Timpl, R., Olsen, B. R., Hjelstuen, M. H. B., Haraldseth, O., & Bjerkvig, R. (2001) · Nature Biotechnology · doi:10.1038/83471 · Cited by 293
Nitric oxide's reactions with hemoglobin: a view through the SNO-storm
Gladwin, M. T., Lancaster, J. R., Freeman, B. A., & Schechter, A. N. (2003) · Nature Medicine · doi:10.1038/nm0503-496 · Cited by 291
Thomas, D. D., Espey, M. G., Ridnour, L. A., Hofseth, L. J., Mancardi, D., Harris, C. C., & Wink, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400453101 · Cited by 289
Immunity to cancer: attack and escape in T lymphocyte–tumor cell interaction
Rivoltini, L., Carrabba, M., Huber, V., Castelli, C., Novellino, L., Dalerba, P., Mortarini, R., Arancia, G., Anichini, A., Fais, S., et al. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18809.x · Cited by 289
Ambs, S., Merriam, W. G., Ogunfusika, M. O., Bennett, W. P., Ishibe, N., Hussain, S. P., Tzeng, E. E., Geller, D. A., Billiar, T. R., & Harris, C. C. (1998) · Nature Medicine · doi:10.1038/3957 · Cited by 287
De Santo, C., Serafini, P., Marigo, I., Dolcetti, L., Bolla, M., Del Soldato, P., Melani, C., Guiducci, C., Colombo, M. P., Iezzi, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409783102 · Cited by 284
Self-citationNitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis
Jaiswal, M., LaRusso, N. F., & Gores, G. J. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.3.g626 · Cited by 278
Role of nitric oxide in tumour progression: Lessons from human tumours
Thomsen, L. L., & Miles, D. W. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1005912906436 · Cited by 276
Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation
Dachs, G. U., & Tozer, G. M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00159-3 · Cited by 272
Riganti, C., Miraglia, E., Viarisio, D., Costamagna, C., Pescarmona, G., Ghigo, D., & Bosia, A. (2005) · Cancer Research · doi:10.1158/0008-5472.516.65.2 · Cited by 271
Nitric oxide in gastrointestinal health and disease
Shah, V., Lyford, G., Gores, G., & Farrugia, G. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.046 · Cited by 267
Wang, E., Miller, L. D., Ohnmacht, G. A., D, S. M. M., Pérez‐Díez, A., Petersen, D. W., Zhao, Y., Simon, R., Powell, J. I., Asaki, E., et al. (2002) · PubMed · Cited by 260
Müerköster, S., Wegehenkel, K., Arlt, A., Witt, M., Sipos, B., Kruse, M.-L., Sebens, T., Klöppel, G., Kalthoff, H., Fölsch, U. R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1860 · Cited by 254
Harmey, J. H., Bucana, C. D., Lu, W., Byrne, A. M., McDonnell, S., Lynch, C., Bouchier‐Hayes, D., & Dong, Z. (2002) · International Journal of Cancer · doi:10.1002/ijc.10632 · Cited by 247
Gratton, J.-P., Lin, M. I., Yu, J., Weiss, E. D., Jiang, Z. L., Fairchild, T. A., Iwakiri, Y., Groszmann, R., Claffey, K. P., Cheng, Y.-C., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00168-5 · Cited by 238
NO, nitrotyrosine, and cyclic GMP in signal transduction.
Hanafy, K. A., Krumenacker, J. S., & Murad, F. (2001) · PubMed · Cited by 236
Current uses of isolated limb perfusion in the clinic and a model system for new strategies
Eggermont, A. M., de Wilt, J. H., & ten Hagen, T. L. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01141-0 · Cited by 235
Kim, Y.-M., Kim, T.-H., Chung, H.-T., Talanian, R. V., Yin, X.-M., & Billiar, T. R. (2000) · Hepatology · doi:10.1053/jhep.2000.18291 · Cited by 235
Ambs, S., Hussain, S. P., & Harris, C. C. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194524 · Cited by 233
Rao, C. V., Cooma, I., Simi, B., Manning, P. T., Connor, J. R., & Reddy, B. S. (2002) · PubMed · Cited by 232
Nitric oxide–mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes
Jaiswal, M., LaRusso, N. F., Shapiro, R. A., Billiar, T. R., & Gores, G. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.20875 · Cited by 230
Nitric oxide signaling in colon cancer chemoprevention
Rao, C. V. (2004) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2004.05.022 · Cited by 216
Nitrated and oxidized plasma proteins in smokers and lung cancer patients.
Pignatelli, B., Li, C., Boffetta, P., Chen, Q., Ahrens, W., Nyberg, F., Mukeria, A., Brüske‐Hohlfeld, I., Fortes, C., Constantinescu, V., et al. (2001) · PubMed · Cited by 215
Nitric oxide in cancer and chemoprevention
Hofseth, L. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01363-1 · Cited by 212
Wu, J., Akaike, T., & Maeda, H. (1998) · PubMed · Cited by 212
Marrogi, A. J., Travis, W. D., Welsh, J. A., Ma, K., Rahim, H., Tazelaar, H. D., Pairolero, P. C., Trastek, V. F., Jett, J. R., Caporaso, N., et al. (2000) · PubMed · Cited by 205
Selective expression of inducible nitric oxide synthase in human prostate carcinoma
Klotz, T., Bloch, W., Volberg, C., Engelmann, U. H., & Addicks, K. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10<1897::aid-cncr12>3.0.co;2-o · Cited by 199
Oxidative stress and S‐nitrosylation of proteins in cells
Beltrán, B., Orsi, A., Clementi, E., & Moncada, S. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703147 · Cited by 196
Vakkala, M. A., Kahlos, K., Lakari, E., Pääkkö, P. K., Kinnula, V. L., & Soini, Y. (2000) · PubMed · Cited by 196
Role of nitric oxide in inflammation
Laroux, F. S., Pavlick, K. P., Hines, I. N., Kawachi, S., Harada, H., Bharwani, S., Hoffman, J. M., & Grisham, M. B. (2001) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2001.00891.x · Cited by 196
Ekmekçioglu, S., Ellerhorst, J. A., Smid, C. M., Prieto, V. G., Munsell, M. F., Buzaid, A. C., & Grimm, E. A. (2000) · PubMed · Cited by 192
Whitmore, M. M., DeVeer, M. J., Edling, A., Oates, R. K., Simons, B., Lindner, D., & Williams, B. R. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0063 · Cited by 183
Xu, W., Liu, L., Charles, I. G., & Moncada, S. (2004) · Nature Cell Biology · doi:10.1038/ncb1188 · Cited by 182
Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis
Albina, J. E., & Reichner, J. S. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1005904704618 · Cited by 181
Thomas, D. D., Espey, M. G., Vitek, M. P., Miranda, K. M., & Wink, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202312699 · Cited by 181
Sonveaux, P., Brouet, A., Havaux, X., Grégoire, V., Dessy, C., Balligand, J., & Féron, O. (2003) · PubMed · Cited by 180
Zhang, H. J., Zhao, W., Venkataraman, S., Robbins, M. E. C., Buettner, G. R., Kregel, K. C., & Oberley, L. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109801200 · Cited by 180
Jadeski, L. C., Hum, K. O., Chakraborty, C., & Lala, P. K. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000401)86:1<30::aid-ijc5>3.0.co;2-i · Cited by 180
Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide.
Jaiswal, M., LaRusso, N. F., Nishioka, N., Nakabeppu, Y., & Gores, G. J. (2001) · PubMed · Cited by 177
Pinlaor, S., Hiraku, Y., Ma, N., Yongvanit, P., Semba, R., Oikawa, S., Murata, M., Sripa, B., Sithithaworn, P., & Kawanishi, S. (2004) · Nitric Oxide · doi:10.1016/j.niox.2004.08.004 · Cited by 177
Rao, C. V., Kawamori, T., Hamid, R., & Reddy, B. S. (1999) · Carcinogenesis · doi:10.1093/carcin/20.4.641 · Cited by 175
Jadeski, L. C., & Lala, P. K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65240-6 · Cited by 174
Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice
Ambs, S., Ogunfusika, M. O., Merriam, W. G., Bennett, W. P., Billiar, T. R., & Harris, C. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8823 · Cited by 171
Nitric oxide involvement in tumor-induced immunosuppression.
Lejeune, P., Lagadec, P., Onier, N., Pinard, D., Ohshima, H., & Jeannin, J. F. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5077 · Cited by 170
Song, W. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00395-8 · Cited by 170
Nitric Oxide-Mediated Regulation of Chemosensitivity in Cancer Cells
Matthews, N. E., Adams, M. A., Maxwell, L. R., Gofton, T. E., & Graham, C. H. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.24.1879 · Cited by 168
Huerta-Yepez, S., Vega, M., Jazirehi, A., Garban, H., Hongo, F., Cheng, G., & Bonavida, B. (2004) · Oncogene · doi:10.1038/sj.onc.1207655 · Cited by 165
Inducible Nitric Oxide Synthase Expression in Human Colorectal Cancer
Cianchi, F., Cortesini, C., Fantappiè, O., Messerini, L., Schiavone, N., Vannacci, A., Nistri, S., Sardi, I., Baroni, G., Marzocca, C., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63876-x · Cited by 161
p53 mutational spectra and the role of methylated CpG sequences
Pfeifer, G. P. (2000) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(00)00022-1 · Cited by 161
Nitric oxide chemistry and cellular signaling
Gow, A. J., & Ischiropoulos, H. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1085 · Cited by 161
Chin, K., Kurashima, Y., Ogura, T., Tajiri, H., Yoshida, S., & Esumi, H. (1997) · Oncogene · doi:10.1038/sj.onc.1201201 · Cited by 161
Garbán, H. J., & Bonavida, B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.75 · Cited by 159
Dhakshinamoorthy, S., & Porter, A. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312492200 · Cited by 159
Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers
Becker, K., Savvides, S. N., Keese, M. A., Schirmer, R. H., & Karplus, P. A. (1998) · Nature Structural Biology · doi:10.1038/nsb0498-267 · Cited by 154
Pipili‐Synetos, E., Papageorgiou, A., Sakkoula, E., Sotiropoulou, G., Fotsis, T., Karakiulakis, G., & Maragoudakis, M. E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16670.x · Cited by 151
Screening for Nitric Oxide-Dependent Protein-Protein Interactions
Matsumoto, A., Comatas, K., Liu, L., & Stamler, J. S. (2003) · Science · doi:10.1126/science.1079319 · Cited by 150
Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production.
Ahn, B., & Ohshima, H. (2001) · PubMed · Cited by 145
Cobbs, C., Whisenhunt, T. R., Wesemann, D. R., Harkins, L. E., Meir, E. G. V., & Samanta, M. (2003) · PubMed · Cited by 144
Bussière, F. I., Chaturvedi, R., Cheng, Y., Gobert, A. P., Asim, M., Blumberg, D. R., Xu, H., Kim, P. Y., Hacker, A., Casero, R. A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400498200 · Cited by 144
Nitric-oxide-donating NSAIDs as agents for cancer prevention
Rigas, B., & Kashfi, K. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.05.004 · Cited by 143
Role of nitric oxide in genotoxicity: Implication for carcinogenesis
Felley‐Bosco, E. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1005948420548 · Cited by 139
Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9.
Torok, N. J., Higuchi, H., Bronk, S. F., & Gores, G. J. (2002) · PubMed · Cited by 139
Williams, J., Borgo, S., Hasan, I., Castillo, E., Traganos, F., & Rigas, B. (2001) · PubMed · Cited by 137
Cyclooxygenase-2 Activation Mediates the Proangiogenic Effect of Nitric Oxide in Colorectal Cancer
Cianchi, F., Cortesini, C., Fantappiè, O., Messerini, L., Sardi, I., Lasagna, N., Perna, F., Fabbroni, V., Felice, A. D., Perigli, G., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0192 · Cited by 136
Kashfi, K., Rayyan, Y. M., QIAO, L., Williams, J. L., Chen, J., Soldato, P. D., Traganos, F., & Rigas, B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042754 · Cited by 134
Xu, W., Liu, L., Smith, G. C. M., & Charles, L. G. (2000) · Nature Cell Biology · doi:10.1038/35014028 · Cited by 127
Cook, T., Wang, Z., Alber, S. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2212 · Cited by 127
Jadeski, L. C., Chakraborty, C., & Lala, P. K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11268 · Cited by 126
Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy
Ricchi, P., Zarrilli, R., di Palma, A., & Acquaviva, A. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600829 · Cited by 125
Ambs, S., Bennett, W. P., Merriam, W. G., Ogunfusika, M. O., Oser, S. M., Khan, M. H., Jones, R., & Harris, C. C. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.470 · Cited by 124
Koblish, H. K., Hunter, C. A., Wysocka, M., Trinchieri, G., & Lee, W. M. F. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1603 · Cited by 122
Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis.
Kisley, L. R., Barrett, B. S., Bauer, A. K., Dwyer‐Nield, L. D., Barthel, B. L., Meyer, A. M., Thompson, D. C., & Malkinson, A. M. (2002) · PubMed · Cited by 121
Nitrosative Stress and Transcription
Kröncke, K. D. (2003) · Biological Chemistry · doi:10.1515/bc.2003.153 · Cited by 119
Nath, N., Kashfi, K., Chen, J., & Rigas, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134840100 · Cited by 118
Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer.
Bing, R. J., Miyataka, M., Rich, K. A., Hanson, N., Wang, L., Slosser, H. D., & Shi, S.-R. (2001) · PubMed · Cited by 118
Reveneau, S., Arnould, L., Jolimoy, G., Hilpert, S., Lejeune, P., Saint-Giorgio, V., Belichard, C., & Jeannin, J. (1999) · PubMed · Cited by 117
Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy
Korbelik, M., Parkins, C. S., Shibuya, H., Cecić, I., Stratford, M. R. L., & Chaplin, D. J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1157 · Cited by 116
Tumor Cell Responses to a Novel Glutathione S-Transferase–Activated Nitric Oxide-Releasing Prodrug
Findlay, V. J., Townsend, D. M., Saavedra, J. E., Buzard, G. S., Citro, M. L., Keefer, L. K., Ji, X., & Tew, K. D. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1070 · Cited by 114
Microencapsulated iNOS‐expressing cells cause tumor suppression in mice
Xu, W., Liu, L., & Charles, I. G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0590fje · Cited by 113
Vickers, S. M., MacMillan-Crow, L. A., Green, M., Ellis, C. M., & Thompson, J. C. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.3.245 · Cited by 113
Bak, A., McKnight, W., Li, P., Soldato, P. D., Calignano, A., Cirino, G., & Wallace, J. L. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00191-x · Cited by 110
Inhibition of Apoptosis Signal-regulating Kinase 1 by Nitric Oxide through a Thiol Redox Mechanism
Park, H.-S., Yu, J., Cho, J., Kim, M.-S., Huh, S.-H., Ryoo, K., & Choi, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m304183200 · Cited by 109
Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies
Hajri, A., Metzger, E., Vallat, F., Coffy, S., Flatter, E., Evrard, S., Marescaux, J., & Aprahamian, M. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.591 · Cited by 109
Nadai, C. D., Sestili, P., Cantoni, O., Lièvremont, J.-P., Sciorati, C., Barsacchi, R., Moncada, S., Meldolesi, J., & Clementi, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070062397 · Cited by 109
Williams, J. L., Nath, N., Chen, J., Hundley, T. R., Gao, J., Kopelovich, L., Kashfi, K., & Rigas, B. (2003) · PubMed · Cited by 109
Wang, X., Zalcenstein, A., & Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401181 · Cited by 108
Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiency
Xie, K., & Huang, S. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01364-3 · Cited by 107
Chao, J., Kuo, P.-C., & Hsu, T.-S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312381200 · Cited by 107
Wang, H. H., McIntosh, A. R., Hasinoff, B. B., Rector, E. S., Ahmed, N., Nance, D. M., & Orr, F. W. (2000) · PubMed · Cited by 106
Tozer, G. M., Prise, V. E., & Chaplin, D. J. (1997) · PubMed · Cited by 105
Effect of the Tumor Vascular-Damaging Agent, ZD6126, on the Radioresponse of U87 Glioblastoma
Wachsberger, P. R., Burd, R., Marero, N., Daskalakis, C., Ryan, A. J., McCue, P. A., & Dicker, A. P. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.835.11.2 · Cited by 105
Marrogi, A. J., Pass, H. I., Khan, M., Metheny‐Barlow, L. J., Harris, C. C., & Gerwin, B. I. (2000) · PubMed · Cited by 105
Losser, M., & Payen, D. (1996) · Seminars in liver disease (Print) · doi:10.1055/s-2007-1007249 · Cited by 104
Heigold, S., Sers, C., Bechtel‐Walz, W., Ivanovas, B., Schäfer, R., & Bauer, G. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.929 · Cited by 102
Antiapoptotic role of endogenous nitric oxide in human melanoma cells.
Salvucci, O., Carsana, M., Bersani, I., Tragni, G., & Anichini, A. (2001) · PubMed · Cited by 97
Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth
Is, P., Kang, S.-W., Shin, Y.-J., Chae, K.-Y., Park, M.-O., Kim, M. Y., Wheatley, D. N., & Min, B.-H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601181 · Cited by 97
Oxygen-mediated Regulation of Tumor Cell Invasiveness
Postovit, L.-M. M., ADAMS, M. A., Lash, G. E., Heaton, J. P. W., & Graham, C. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204529200 · Cited by 96
INDUCIBLE NITRIC OXIDE SYNTHASE WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER
Swana, H. S., Smith, S. D., Perrotta, P. L., SAITO, N., Wheeler, M. A., & WEISS, R. M. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61985-2 · Cited by 95
Accumulation of 8-nitroguanine in human gastric epithelium induced by Helicobacter pylori infection
Ma, N., Adachi, Y., Hiraku, Y., Horiki, N., Horiike, S., Imoto, I., Pinlaor, S., Murata, M., Semba, R., & Kawanishi, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.193 · Cited by 95
The role of early expression of inducible nitric oxide synthase in human breast cancer
Loibl, S., Buck, A., Strank, C., von Minckwitz, G., Roller, M., Sinn, H., Schini‐Kerth, V. B., Solbach, C., Strebhardt, K., & Kaufmann, M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.07.010 · Cited by 93
Pervin, S., Singh, R., Freije, W. A., & Chaudhuri, G. (2003) · PubMed · Cited by 93
Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis.
Shi, Q., Xiong, Q., Wang, B., Le, X., Khan, N. A., & Xie, K. (2000) · PubMed · Cited by 93
Loibl, S., von Minckwitz, G., Weber, S. P., Sinn, H., Schini‐Kerth, V. B., Lobysheva, I. I., Nepveu, F., Wolf, G., Strebhardt, K., & Kaufmann, M. (2002) · Cancer · doi:10.1002/cncr.10817 · Cited by 92
Activation of the Endothelial Nitric-oxide Synthase by Tumor Necrosis Factor-α
Bulotta, S., Barsacchi, R., Rotiroti, D., Borgese, N., & Clementi, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006535200 · Cited by 91
Tang, C., & Grimm, E. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310821200 · Cited by 90
Juang, S., Xie, K., Xu, L., Shi, Q., Wang, Y., Yoneda, J., & Fidler, I. J. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.6-845 · Cited by 89
Raspollini, M. R., Amunni, G., Villanucci, A., Boddi, V., Baroni, G., Taddei, A., & Taddei, G. L. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.023 · Cited by 87
Xie, K., Huang, S., Dong, Z., Juang, S., Wang, Y., & Fidler, I. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.6.421 · Cited by 86
Marrogi, A. J., Ma, K., van Gijssel, H. E., Welsh, J. A., Rahim, H., Demetris, A. J., Kowdley, K. V., Hussain, S. P., Nair, J. R., Bartsch, H., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1652 · Cited by 85
Jordan, B. F., Sonveaux, P., Féron, O., Grégoire, V., Beghein, N., Dessy, C., & Gallez, B. (2004) · International Journal of Cancer · doi:10.1002/ijc.20046 · Cited by 85
Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions
Massi, D., Franchi, A., Sardi, I., Magnelli, L., Paglierani, M., Borgognoni, L., Reali, U. M., & Santucci, M. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200106)194:2<194::aid-path851>3.0.co;2-s · Cited by 83
Matrix metalloproteinase 13 mediates nitric oxide activation of endothelial cell migration
López-Rivera, E., Lizarbe, T. R., Martínez‐Moreno, M., López-Novoa, J. M., Rodríguez‐Barbero, A., Rodrigo, J., Fernández, A. P., Alvarez, A. M., Lamas, S., & Zaragoza, C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408217102 · Cited by 82
Nitric oxide induces phosphorylation of p53 and impairs nuclear export
Schneiderhan‐Marra, N., Budde, A., Zhang, Y., & Brüne, B. (2003) · Oncogene · doi:10.1038/sj.onc.1206431 · Cited by 81
Kashfi, K., Borgo, S., Williams, J. L., Chen, J., Gao, J., Glekas, A., Benedini, F., Soldato, P. D., & Rigas, B. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075994 · Cited by 80
Gallo, O., Schiavone, N., Papucci, L., Sardi, I., Magnelli, L., Franchi, A., Masini, E., & Capaccioli, S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63699-1 · Cited by 79
Ishii, Y., Ogura, T., Tatemichi, M., Fujisawa, H., Otsuka, F., & Esumi, H. (2002) · International Journal of Cancer · doi:10.1002/ijc.10808 · Cited by 79
Kim, J., & Tannenbaum, S. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312722200 · Cited by 78
Millet, A., Bettaïeb, A., Renaud, F., Prévotat, L., Hammann, A., Solary, É., Mignotte, B., & Jeannin, J. (2002) · Gastroenterology · doi:10.1053/gast.2002.34310 · Cited by 77
Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with downregulation of Bcl-2
Xie, K., Wang, Y., Huang, S., Xu, L., Bielenberg, D. R., Salas, T. R., McConkey, D. J., Jiang, W., & Fidler, I. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201239 · Cited by 77
Cited by
Gold nanoparticles in delivery applications☆
GHOSH, P., HAN, G., DE, M., KIM, C., & ROTELLO, V (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.016 · Cited by 2,694
Nitric oxide release: Part II. Therapeutic applications
Carpenter, A. W., & Schoenfisch, M. H. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15273h · Cited by 964
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
Anderson, K. G., Stromnes, I. M., & Greenberg, P. D. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.008 · Cited by 702
Metabolites and the Tumour Microenvironment: From Cellular Mechanisms to Systemic Metabolism
Elia, I., & Haigis, M. C. (2021) · Nature Metabolism · doi:10.1038/s42255-020-00317-z · Cited by 651
A Review on the Synthesis and Functionalization of Gold Nanoparticles as a Drug Delivery Vehicle
Amina, S. J., & Guo, B. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s279094 · Cited by 561
Metadata
- Authors
- Mocellin, S., Bronte, V., & Nitti, D.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2006-09-21
- Volume
- 27
- Issue
- 3
- Pages
- 317-352
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2098652851
- Cited by
- 478
- References
- 278
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.